Brigham and Women's Hospital
Katherine P Liao
Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start preventative treatment earlier.
Rheumatoid Arthritis (RA
Atherosclerotic Cardiovascular Disease (ASCVD)
high sensitivity cardiac troponin
The objective of this study is to test the utility of high sensitivity cardiac troponin (hs-cTn) and coronary artery calcium (CAC) in risk stratifying patients with rheumatoid arthritis (RA) who may benefit from lipid lowering therapy. The population of interest are individuals who would not otherwise be recommended for therapy based on general population risk calculators for heart disease risk.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 120 participants |
| Official Title : | The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study |
| Actual Study Start Date : | 2024-09-04 |
| Estimated Primary Completion Date : | 2028-03-04 |
| Estimated Study Completion Date : | 2028-03-04 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 35 Years to 79 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Brigham and Womens Hospital
Boston, Massachusetts, United States, 02115